
|Articles|July 2, 2017
Orphan Drug Evaluation Overhaul Highlights AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Heidi Overton's FDA Nomination Could Mean for Pharmacy
2
August 2026 in Oncology: FDA Approvals and Phase 3 Data Reshape Treatment Across Tumor Types
3
New Lipid Drugs and What Pharmacists Need to Know
4
FDA Approves Tirzepatide to Cut CV Risk in Type 2 Diabetes
5


































































































